Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: allogeneic T lymphocytes BPX-501Find trials that include: Any drugs shown Results 1-4 of 4 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant Status: ActivePhase: Phase II, Phase IType: TreatmentAge: 18 to 65Trial IDs: BP-HM-001, NCI-2013-00518, NCT01744223 2. Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant Status: ActivePhase: Phase II, Phase IType: TreatmentAge: 3 months to 21 yearsTrial IDs: BP-004, NCI-2015-01890, NCT02065869 3. Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases Status: ActivePhase: Phase IType: Supportive care, TreatmentAge: 4 months to 54 yearsTrial IDs: BP-003, NCI-2014-02100, NCT02231710 4. Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant Status: ActivePhase: Phase IType: TreatmentAge: 1 to 65Trial IDs: BP-008, NCI-2016-01336, NCT02477878 Select All on Page Start Over
